Jefferies & Company

In a report published Friday, Jefferies & Company reiterated its Buy rating on Power-One (NASDAQ: PWER), but slightly lowered its price target from $6.00 to $5.00. Jefferies noted, “The company preannounced 4Q12 rev of $190-195M vs. prev $210-230M and a $12-15M loss. Margin pressure was...

In a report published Friday, Jefferies & Company reiterated its Buy rating on salesforce.com (NYSE: CRM), and raised its price target from $180.00 to $200.00. Jefferies noted, “We remain positive on CRM after hosting investor meetings with mgmt, undertaking some checks with partners and re-...

In a report published Friday, Jefferies & Company reiterated its Buy rating on Symantec Corporation (NASDAQ: SYMC), and raised its price target from $23.00 to $25.00. Jefferies noted, “We look for a broad framework encompassing the growth strategy, operational structure and capital...

In a report published Friday, Jefferies & Company downgraded its rating on Finisar Corporation (NASDAQ: FNSR) from Hold to Underperform, and lowered its price target from $14.00 to $7.50. Jefferies noted, “Our checks and a recent public announcement from Intel suggest that the ultimate...

In a report published Friday, Jefferies & Company upgraded its rating on Research In Motion Limited (NASDAQ: RIMM) to Buy, and raised its price target from $13.00 to $19.50. Jefferies noted, “1) RIM will enable corporate email on iPhones and Android devices. This change we believe is unknown...

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Cemex (NYSE: CX), and raised its price target from $9.70 to $13.00. Jefferies & Company noted, “We are increasing our target prices for six of the global cement companies; Buzzi Unicem (+€3.4 on the...

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Dana Holding Corporation (NYSE: DAN), and raised its price target from $16.00 to $19.00. Jefferies & Company noted, “DAN guided 2013 revenue, EBITDA, and EPS modestly below consensus, with the shortfall...

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Pfizer (NYSE: PFE), and raised its price target from $27.00 to $31.00. Jefferies & Company noted, “We see Pharmaceuticals as remaining attractive in 2013, but unlikely to return the same level of relative...

In a report published Wednesday, Jefferies & Company reiterated its Hold rating on Merck & Co. (NYSE: MRK), but lowered its price target from $49.00 to $47.00. Jefferies & Company noted, “We see Pharmaceuticals as remaining attractive in 2013, but unlikely to return the same level of...

In a report published Wednesday, Jefferies & Company reiterated its Hold rating on Johnson & Johnson (NYSE: JNJ), and raised its price target from $75.00 to $79.00. Jefferies & Company noted, “We see Pharmaceuticals as remaining attractive in 2013, but unlikely to return the same level...

In a report published Wednesday, Jefferies & Company reiterated its Underperform rating on Eli Lilly & Co. (NYSE: LLY), and raised its price target from $36.00 to $43.00. Jefferies & Company noted, “We see Pharmaceuticals as remaining attractive in 2013, but unlikely to return the same...

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Bristol Myers Squibb Co. (NYSE: BMY), and slightly raised its price target from $38.00 to $39.00. Jefferies & Company noted, “We see Pharmaceuticals as remaining attractive in 2013, but unlikely to return the...

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Abbott Laboratories (NYSE: ABT), but lowered its price target from $87.00 to $39.00. Jefferies & Company noted, “We see Pharmaceuticals as remaining attractive in 2013, but unlikely to return the same level...

In a report published Wednesday, Jefferies & Company reiterated its Hold rating on Edison International (NYSE: EIX), but lowered its price target from $51.00 to $48.50. Jefferies & Company noted, “We are reducing our 4Q and full year 2012 EPS estimate by $0.15 to $1.05 and $3.15,...

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Regional Management Corporation (NYSE: RM), but slightly lowered its price target from $23.00 to $22.00. Jefferies & Company noted, “Last night, RM pre-announced 4Q12 EPS and provided selected preliminary...